merrill lynch and analyst richard vietor said reiterated buy recommendation several drug stocks today stocks were bristol myers which rose 101 schering plough corp and syntex corp vietor described these stocks middle group performers vietor said prices these stocks pretty cheap relative leading performers drug group such upjohn merck and inc and squibb corp vietor said also mentioned pfizer inc two and warner lambert being middle group but did not recommend those stocks which rates neutral reuter 